Companies / ENL

ENLITIC INC.

ASX:ENLHealth Care Equipment & Services
833.2M shares on issueASX (delayed) · as of 28 July 2026$0.007price · delayed$5.8Mmarket cap · indicative
D
Dilution grade

Share count grew 958% in 24 months; 3 cash raises in 24 months; options/rights overhang 127% of shares

Cash runway4.9 quarters of funding
Share-count growth (24m)958.5%
Raise cadence (24m)3 cash raises
Options & rights overhang127.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

ENLITIC INC.'s ordinary share count grew 958.5% between May 2024 and April 2026, to 833M shares. The company raised capital three times in that period for total disclosed proceeds of A$34.0M, most recently a A$16.0M placement in June 2026. Options and rights on issue could convert into 1.06B new shares, equal to 127.1% of the current share count, of which 0% are in the money; the nearest expiry falls in October 2028. At the March 2026 quarter the company reported A$14.2M in available cash, about 4.9 quarters of funding at its recent spending rate. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in August 2026.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
127.1%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
4.9 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 833.2M per ASX (delayed) (28 July 2026).
629.7M704.4M779.1MDec 24Sept 25July 26Cash raise · 30 June 2026Cash raise · 19 Dec 2025Cash raise · 30 Apr 2025

Cash runway

4.9 qtrs
More than four quarters of funding at the recent spend rate.
$14.2M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
13 July 20263H · cancellationCHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED833.2MAppendix 3H
13 July 20263G · unquotedCHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED833.2MAppendix 3G
13 Apr 20262A · quoted issueCHESS DEPOSITARY INTERESTS 1:1 US833.2MAppendix 2A
13 Apr 20263H · cancellationCHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED833.2MAppendix 3H
10 Feb 20263G · unquotedCHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED833.2MAppendix 3G
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

3 cash raises in the last 24 months · 2 in the last 12 months

$16.0M
Placement
30 June 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Join the waitlist

Options & convertible securities

127.1%
Total overhang · of current shares
0.0%
In the money · at current price
1.06B
Potential new shares
Oct 2028
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
10 Feb 2026Sergio DuchiniOther——$25k3Y notice
10 Feb 2026Michael SistenichOther——$100k3Y notice
13 June 2025Michael SistenichOther1.3M625k—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

15 July 2026Extraordinary General (Special) Meeting Documents
13 July 2026ASX waivers in connection with SPP
13 July 2026Notification of cessation of securities - ENL
13 July 2026Notification regarding unquoted securities - ENL
2 July 2026Proposed issue of securities - ENL
2 July 2026$PInvestor Presentation - Capital Raising and CN Conversion
2 July 2026$PA$15m Conditional Placement and Proposed Note Conversion
30 June 2026$PFirst Australian Ensight Contract Secured with Lumus Imaging
30 June 2026$PTrading Halt
11 May 2026$PEnsight go-live at NZs largest private radiology provider
28 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
23 Apr 2026Results of Meeting
22 Apr 2026AGM Chair Address and Presentations
13 Apr 2026Application for quotation of securities - ENL
13 Apr 2026Notification of cessation of securities - ENL
31 Mar 2026Notice of Annual General Meeting/Proxy Form
31 Mar 2026$PUS$1.2m imaging data migration contract with Parkland Health
30 Mar 2026$PContract Secured with St. Jude Childrens Research Hospital
22 Mar 2026$PData Migration Contract with Penn Medicine
26 Feb 2026Corporate Governance Statement & Appendix 4G

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.